The prevailing paradigm of T lymphocyte control of viral replication is that the protective capacity of virus-specific CD8+ T cells is directly proportional to the number of functions they can perform, with IL-2 production capacity considered critical. Having recently defined rapid perforin upregulation as a novel effector function of antigen-specific CD8+ T cells, here we sought to determine whether new perforin production is a component of polyfunctional CD8+ T cell responses that contributes to the control of several human viral infections: cytomegalovirus (CMV), Epstein-Barr virus (EBV), influenza (flu), and adenovirus (Ad). We stimulated normal human donor PBMC with synthetic peptides whose amino acid sequences correspond to defined CTL epitopes in the aforementioned viruses, and then used polychromatic flow cytometry to measure the functional capacity and the phenotype of the responding CD8+ T cells. While EBV and flu-specific CD8+ T cells rarely upregulate perforin, CMV-specific cells often do and Ad stimulates an exceptionally strong perforin response. The differential propensity of CD8+ T cells to produce either IL-2 or perforin is in part related to levels of CD28 and the transcription factor T-bet, as CD8+ T cells that rapidly upregulate perforin harbor high levels of T-bet and those producing IL-2 express high amounts of CD28. Thus, “polyfunctional” profiling of antigen-specific CD8+ T cells must not be limited to simply the number of functions the cell can perform, or one particular memory phenotype, but should actually define which combinations of memory markers and functions are relevant in each pathogenic context.
Vyšlo v časopise: Perforin and IL-2 Upregulation Define Qualitative Differences among Highly Functional Virus-Specific Human CD8 T Cells. PLoS Pathog 6(3): e32767. doi:10.1371/journal.ppat.1000798 Kategorie: Research Article prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1000798
1. AmyesE
HattonC
Montamat-SicotteD
GudgeonN
RickinsonAB
2003 Characterization of the CD4+ T cell response to Epstein-Barr virus during primary and persistent infection. J Exp Med 198 903 911
2. CallanMF
2003 The evolution of antigen-specific CD8+ T cell responses after natural primary infection of humans with Epstein-Barr virus. Viral Immunol 16 3 16
3. BelzGT
DohertyPC
2001 Virus-specific and bystander CD8+ T-cell proliferation in the acute and persistent phases of a gammaherpesvirus infection. J Virol 75 4435 4438
4. DohertyPC
ChristensenJP
BelzGT
StevensonPG
SangsterMY
2001 Dissecting the host response to a gamma-herpesvirus. Philos Trans R Soc Lond B Biol Sci 356 581 593
5. GillespieGM
WillsMR
AppayV
O'CallaghanC
MurphyM
2000 Functional heterogeneity and high frequencies of cytomegalovirus-specific CD8(+) T lymphocytes in healthy seropositive donors. J Virol 74 8140 8150
6. GuidottiLG
IshikawaT
HobbsMV
MatzkeB
SchreiberR
1996 Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 4 25 36
7. GuidottiLG
RochfordR
ChungJ
ShapiroM
PurcellR
1999 Viral clearance without destruction of infected cells during acute HBV infection. Science 284 825 829
8. MoriyamaT
GuilhotS
KlopchinK
MossB
PinkertCA
1990 Immunobiology and pathogenesis of hepatocellular injury in hepatitis B virus transgenic mice. Science 248 361 364
9. LechnerF
WongDK
DunbarPR
ChapmanR
ChungRT
2000 Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med 191 1499 1512
10. ThimmeR
BukhJ
SpangenbergHC
WielandS
PembertonJ
2002 Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease. Proc Natl Acad Sci U S A 99 15661 15668
11. MakedonasG
BettsMR
2006 Polyfunctional analysis of human t cell responses: importance in vaccine immunogenicity and natural infection. Springer Semin Immunopathol 28 209 219
12. SederRA
DarrahPA
RoedererM
2008 T-cell quality in memory and protection: implications for vaccine design. Nat Rev Immunol 8 247 258
13. HarariA
DutoitV
CelleraiC
BartPA
Du PasquierRA
2006 Functional signatures of protective antiviral T-cell immunity in human virus infections. Immunol Rev 211 236 254
14. PantaleoG
HarariA
2006 Functional signatures in antiviral T-cell immunity for monitoring virus-associated diseases. Nat Rev Immunol 6 417 423
15. ZimmerliSC
VallelianF
2005 HIV-1-specific IFN-gamma/IL-2-secreting CD8 T cells support CD4-independent proliferation of HIV-1-specific CD8 T cells. Proc Natl Acad Sci U S A 102 7239 7244
16. DarrahPA
PatelDT
De LucaPM
LindsayRW
DaveyDF
2007 Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat Med 13 843 850
17. HeuselJW
WesselschmidtRL
ShrestaS
RussellJH
LeyTJ
1994 Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells. Cell 76 977 987
18. PodackER
YoungJD
CohnZA
1985 Isolation and biochemical and functional characterization of perforin 1 from cytolytic T-cell granules. Proc Natl Acad Sci U S A 82 8629 8633
19. PetersPJ
BorstJ
OorschotV
FukudaM
KrahenbuhlO
1991 Cytotoxic T lymphocyte granules are secretory lysosomes, containing both perforin and granzymes. J Exp Med 173 1099 1109
20. ShiverJW
HenkartPA
1991 A noncytotoxic mast cell tumor line exhibits potent IgE-dependent cytotoxicity after transfection with the cytolysin/perforin gene. Cell 64 1175 1181
21. BolithoP
VoskoboinikI
TrapaniJA
SmythMJ
2007 Apoptosis induced by the lymphocyte effector molecule perforin. Curr Opin Immunol 19 339 347
22. VoskoboinikI
2006 Perforin-mediated target-cell death and immune homeostasis. Nat Rev Immunol 6 940 952
23. HerspergerAR
MakedonasG
2008 Flow cytometric detection of perforin upregulation in human CD8 T cells. Cytometry A
24. MakedonasG
BanerjeePP
PandeyR
HerspergerAR
SanbornKB
2009 Rapid up-regulation and granule-independent transport of perforin to the immunological synapse define a novel mechanism of antigen-specific CD8+ T cell cytotoxic activity. J Immunol 182 5560 5569
25. LeenAM
SiliU
VaninEF
JewellAM
XieW
2004 Conserved CTL epitopes on the adenovirus hexon protein expand subgroup cross-reactive and subgroup-specific CD8+ T cells. Blood 104 2432 2440
26. Crawford-MikszaL
SchnurrDP
1996 Analysis of 15 adenovirus hexon proteins reveals the location and structure of seven hypervariable regions containing serotype-specific residues. J Virol 70 1836 1844
27. SmythMJ
KellyJM
SuttonVR
DavisJE
BrowneKA
2001 Unlocking the secrets of cytotoxic granule proteins. J Leukoc Biol 70 18 29
28. CatalfamoM
2003 Perforin and the granule exocytosis cytotoxicity pathway. Curr Opin Immunol 15 522 527
29. BettsMR
BrenchleyJM
PriceDA
De RosaSC
DouekDC
2003 Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J Immunol Methods 281 65 78
30. BettsMR
KoupRA
2004 Detection of T-cell degranulation: CD107a and b. Methods Cell Biol 75 497 512
31. HamannD
BaarsPA
RepMH
HooibrinkB
Kerkhof-GardeSR
1997 Phenotypic and functional separation of memory and effector human CD8+ T cells. J Exp Med 186 1407 1418
32. AppayV
CallanM
KlenermanP
GillespieGM
2002 Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat Med 8 379 385
33. BaarsPA
Ribeiro Do CoutoLM
LeusenJH
KuijpersTW
2000 Cytolytic mechanisms and expression of activation-regulating receptors on effector-type CD8+CD45RA+CD27 − human T cells. J Immunol 165 1910 1917
34. GamadiaLE
RemmerswaalEB
WeelJF
BemelmanF
van LierRA
2003 Primary immune responses to human CMV: a critical role for IFN-gamma-producing CD4+ T cells in protection against CMV disease. Blood 101 2686 2692
35. HardingFA
AllisonJP
1993 CD28-B7 interactions allow the induction of CD8+ cytotoxic T lymphocytes in the absence of exogenous help. J Exp Med 177 1791 1796
36. KoulovaL
ClarkEA
ShuG
DupontB
1991 The CD28 ligand B7/BB1 provides costimulatory signal for alloactivation of CD4+ T cells. J Exp Med 173 759 762
37. IntlekoferAM
TakemotoN
WherryEJ
LongworthSA
NorthrupJT
2005 Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin. Nat Immunol 6 1236 1244
38. SullivanBM
JuedesA
SzaboSJ
von HerrathM
GlimcherLH
2003 Antigen-driven effector CD8 T cell function regulated by T-bet. Proc Natl Acad Sci U S A 100 15818 15823
39. SzaboSJ
SullivanBM
StemmannC
SatoskarAR
SleckmanBP
2002 Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells. Science 295 338 342
40. TakahashiN
MatsumotoK
SaitoH
NankiT
MiyasakaN
2009 Impaired CD4 and CD8 effector function and decreased memory T cell populations in ICOS-deficient patients. J Immunol 182 5515 5527
41. SylwesterAW
MitchellBL
EdgarJB
TaorminaC
PelteC
2005 Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects. J Exp Med 202 673 685
42. GarnettCT
ErdmanD
XuW
GoodingLR
2002 Prevalence and quantitation of species C adenovirus DNA in human mucosal lymphocytes. J Virol 76 10608 10616
43. De JongJC
WermenbolAG
Verweij-UijterwaalMW
SlaterusKW
Wertheim-Van DillenP
1999 Adenoviruses from human immunodeficiency virus-infected individuals, including two strains that represent new candidate serotypes Ad50 and Ad51 of species B1 and D, respectively. J Clin Microbiol 37 3940 3945
44. LanzavecchiaA
SallustoF
2000 Dynamics of T lymphocyte responses: intermediates, effectors, and memory cells. Science 290 92 97
45. SallustoF
LenigD
ForsterR
LippM
LanzavecchiaA
1999 Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401 708 712
46. FaintJM
AnnelsNE
CurnowSJ
ShieldsP
PillingD
2001 Memory T cells constitute a subset of the human CD8+CD45RA+ pool with distinct phenotypic and migratory characteristics. J Immunol 167 212 220
47. WillsMR
OkechaG
WeekesMP
GandhiMK
SissonsPJ
2002 Identification of naive or antigen-experienced human CD8(+) T cells by expression of costimulation and chemokine receptors: analysis of the human cytomegalovirus-specific CD8(+) T cell response. J Immunol 168 5455 5464
48. RoosMT
HamannD
KnolGJ
VerhoofstadI
2000 Changes in the composition of circulating CD8+ T cell subsets during acute epstein-barr and human immunodeficiency virus infections in humans. J Infect Dis 182 451 458
49. MillerJD
van der MostRG
AkondyRS
GlidewellJT
AlbottS
2008 Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines. Immunity 28 710 722
50. AlmeidaJR
SauceD
PapagnoL
ShinSY
2009 Antigen sensitivity is a major determinant of CD8+ T-cell polyfunctionality and HIV-suppressive activity. Blood 113 6351 6360
51. IntlekoferAM
KaoC
BanerjeeA
SchambachF
2007 Requirement for T-bet in the aberrant differentiation of unhelped memory CD8+ T cells. J Exp Med 204 2015 2021
52. JoshiNS
CuiW
ChandeleA
LeeHK
UrsoDR
2007 Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor. Immunity 27 281 295
53. HwangES
HongJH
2005 IL-2 production in developing Th1 cells is regulated by heterodimerization of RelA and T-bet and requires T-bet serine residue 508. J Exp Med 202 1289 1300
54. SzaboSJ
KimST
CostaGL
ZhangX
FathmanCG
2000 A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100 655 669
55. TakemotoN
IntlekoferAM
ReinerSL
2006 Cutting Edge: IL-12 inversely regulates T-bet and eomesodermin expression during pathogen-induced CD8+ T cell differentiation. J Immunol 177 7515 7519
56. ChattopadhyayPK
HarperTF
YuJ
2006 Quantum dot semiconductor nanocrystals for immunophenotyping by polychromatic flow cytometry. Nat Med 12 972 977
Zvýšte si kvalifikáciu online z pohodlia domova
Nemáte účet? Registrujte sa
Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.
